DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Celgene (NASDAQ: CELG)



company name or ticker

ETF Outlook: SPDR S&P Biotech ETF (XBI)

5 Things Celgene Corporation's Management Wants You to Know

Who better to tell Celgene's story than its own management team. Here are five of the most important quotes from the company's second-quarter conference call and why they're so important for investors.

12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds

3 Stocks Reiterated As A Buy: CAT, CELG, DIS

Drugs Stocks On The Rise With Help From 3 Stocks

2 Huge Immunology Opportunities For Celgene

Mylan Misses Q2 Earnings and Sales Estimates, Adjusts View - Analyst Blog

Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

Why Investors Should Closely Watch Celgene

Amgen's Multiple Myeloma Drug Kyprolis Succeeds - Analyst Blog

See More Articles...